About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4461160
Allelic
Composition
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
Genetic
Background
B6.Cg-Tnfrsf1atm2.1Rsie
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tnfrsf1atm2.1Rsie mutation (0 available); any Tnfrsf1a mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice treated with 5 ng/g LPS and D-galactosamine exhibit increased mortality unlike similarly treated wild-type mice (J:160543)
• Background Sensitivity: mice on a C57BL/6 background are less sensitive to LPS and D-galactosamine than mice on a 129S6 background (J:160543)
• however, mortality at 10 ng/g LPS and D-galactosamine is normal (J:160543)
• mice treated with 5 ng/g LPS and D-galactosamine exhibit increased mortality unlike similarly treated wild-type mice (J:160543)
• Background Sensitivity: mice on a C57BL/6 background are less sensitive to LPS and D-galactosamine than mice on a 129S6 background (J:160543)
• however, mortality at 10 ng/g LPS and D-galactosamine is normal (J:160543)

immune system
• TNF-stimulated peritoneal macrophages produce less IL6 than similarly treated wild-type cells (J:160543)
• TNF-stimulated peritoneal macrophages produce less IL6 than similarly treated wild-type cells (J:160543)
• following LPS challenge (J:160543)
• following LPS challenge (J:160543)
• following LPS challenge (J:160543)
• following LPS challenge (J:160543)
• TNF-stimulated peritoneal macrophages produce less IL6 than similarly treated wild-type cells (J:160543)
• TNF-stimulated peritoneal macrophages produce less IL6 than similarly treated wild-type cells (J:160543)
• LPS-stimulated mouse embryonic fibroblasts exhibit increased IL6 secretion that is enhanced by application of TNFR2-Fc compared with similarly treated wild-type cells (J:160543)
• LPS-stimulated mouse embryonic fibroblasts exhibit increased IL6 secretion that is enhanced by application of TNFR2-Fc compared with similarly treated wild-type cells (J:160543)
• mice treated with LPS and D-galactosamine exhibit increased mortality unlike similarly treated wild-type mice (J:160543)
• Background Sensitivity: mice on a C57BL/6 background are less sensitive to LPS and D-galactosamine than mice on a 129S6 background (J:160543)
• however, mortality at 10 ng/g LPS and D-galactosamine is normal (J:160543)
• mice treated with LPS and D-galactosamine exhibit increased mortality unlike similarly treated wild-type mice (J:160543)
• Background Sensitivity: mice on a C57BL/6 background are less sensitive to LPS and D-galactosamine than mice on a 129S6 background (J:160543)
• however, mortality at 10 ng/g LPS and D-galactosamine is normal (J:160543)

homeostasis/metabolism
• following LPS challenge (J:160543)
• following LPS challenge (J:160543)
• following LPS challenge (J:160543)
• following LPS challenge (J:160543)

hematopoietic system
• TNF-stimulated peritoneal macrophages produce less IL6 than similarly treated wild-type cells (J:160543)
• TNF-stimulated peritoneal macrophages produce less IL6 than similarly treated wild-type cells (J:160543)

Mouse Models of Human Disease
OMIM ID Ref(s)
Periodic Fever, Familial, Autosomal Dominant 142680 J:160543


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory